Search research articles
Contact Us
Filters
Showing results (11-20 of 189) with videos related to
Page
of 19
Sort By:
Diabetes Care
|
February 23, 2017
Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action
Fernando Bril, Kenneth Cusi
The American Journal of Medicine
|
February 5, 2020
Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know?
Jeffrey Budd, Kenneth Cusi
Current Diabetes Reports
|
October 5, 2020
Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease
Jeffrey Budd, Kenneth Cusi
JHEP Reports : Innovation in Hepatology
|
February 11, 2020
From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
Amalia Gastaldelli, Kenneth Cusi
Annals of Medicine
|
April 9, 2009
New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)
Rafeeq Ali, Kenneth Cusi
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
September 18, 2017
Glucagon like peptide-1 receptor agonists for the management of obesity and non-alcoholic fatty liver disease: a novel therapeutic option
Gauri Dhir, Kenneth Cusi
Diabetes & Vascular Disease Research
|
November 21, 2007
The role of fenofibrate in clinical practice
Alberto Zambon, Kenneth Cusi
Diabetes Spectrum : a Publication of the American Diabetes Association
|
February 22, 2024
Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies
Idoia Genua, Kenneth Cusi
The American Journal of Medicine
|
September 24, 2011
Unmet needs in Hispanic/Latino patients with type 2 diabetes mellitus
Kenneth Cusi, Gloria L Ocampo
Endocrinology and Metabolism Clinics of North America
|
November 9, 2016
Prediabetes: A Worldwide Epidemic
Catherine M Edwards, Kenneth Cusi
Page
of 19
Search research articles
Search
Showing results (11-20 of 189) with videos related to
Sort By:
Page
of 19
Diabetes Care
|
February 23, 2017
Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action
Fernando Bril, Kenneth Cusi
The American Journal of Medicine
|
February 5, 2020
Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know?
Jeffrey Budd, Kenneth Cusi
Current Diabetes Reports
|
October 5, 2020
Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease
Jeffrey Budd, Kenneth Cusi
JHEP Reports : Innovation in Hepatology
|
February 11, 2020
From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
Amalia Gastaldelli, Kenneth Cusi
Annals of Medicine
|
April 9, 2009
New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)
Rafeeq Ali, Kenneth Cusi
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
September 18, 2017
Glucagon like peptide-1 receptor agonists for the management of obesity and non-alcoholic fatty liver disease: a novel therapeutic option
Gauri Dhir, Kenneth Cusi
Diabetes & Vascular Disease Research
|
November 21, 2007
The role of fenofibrate in clinical practice
Alberto Zambon, Kenneth Cusi
Diabetes Spectrum : a Publication of the American Diabetes Association
|
February 22, 2024
Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies
Idoia Genua, Kenneth Cusi
The American Journal of Medicine
|
September 24, 2011
Unmet needs in Hispanic/Latino patients with type 2 diabetes mellitus
Kenneth Cusi, Gloria L Ocampo
Endocrinology and Metabolism Clinics of North America
|
November 9, 2016
Prediabetes: A Worldwide Epidemic
Catherine M Edwards, Kenneth Cusi
Page
of 19